Argen-X (ARGX) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.087x

Based on the latest financial reports, Argen-X (ARGX) has a cash flow conversion efficiency ratio of 0.087x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€735.92 Million ≈ $860.37 Million USD) by net assets (€8.42 Billion ≈ $9.84 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Argen-X worth for the company's overall valuation and market capitalisation.

Argen-X - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Argen-X's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Argen-X (ARGX) stock price for real-time trading data and today's change.

Argen-X Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Argen-X ranked by their cash flow conversion efficiency. Review ARGX cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
Ford Motor Company NYSE:F	0.122x
E.ON SE F:EOAA	0.141x
E.ON SE F:EOAN	0.141x
State Street Corp NYSE:STT	-0.082x
Erste Group Bank AG VI:EBS	-0.063x
Hindustan Unilever Limited NSE:HINDUNILVR	0.128x
Franco-Nevada Corporation TO:FNV	0.057x
Skandinaviska Enskilda Banken AB (publ) ST:SEB-A	0.151x

Annual Cash Flow Conversion Efficiency for Argen-X (2011–2025)

The table below shows the annual cash flow conversion efficiency of Argen-X from 2011 to 2025. Also see ARGX asset base for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€7.32 Billion ≈ $8.56 Billion	€882.43 Million ≈ $1.03 Billion	0.120x	+900.59%
2024-12-31	€5.50 Billion ≈ $6.43 Billion	€-82.75 Million ≈ $-96.74 Million	-0.015x	+85.33%
2023-12-31	€4.10 Billion ≈ $4.79 Billion	€-420.33 Million ≈ $-491.41 Million	-0.103x	+66.55%
2022-12-31	€2.81 Billion ≈ $3.29 Billion	€-862.81 Million ≈ $-1.01 Billion	-0.307x	-28.06%
2021-12-31	€2.53 Billion ≈ $2.96 Billion	€-606.81 Million ≈ $-709.43 Million	-0.239x	-0.60%
2020-12-31	€1.67 Billion ≈ $1.96 Billion	€-398.46 Million ≈ $-465.85 Million	-0.238x	-285.30%
2019-12-31	€1.18 Billion ≈ $1.38 Billion	€151.63 Million ≈ $177.27 Million	0.128x	+228.46%
2018-12-31	€615.87 Million ≈ $720.02 Million	€-61.59 Million ≈ $-72.00 Million	-0.100x	+5.62%
2017-12-31	€413.81 Million ≈ $483.79 Million	€-43.84 Million ≈ $-51.26 Million	-0.106x	-163.35%
2016-12-31	€66.65 Million ≈ $77.92 Million	€11.15 Million ≈ $13.03 Million	0.167x	+144.86%
2015-12-31	€40.76 Million ≈ $47.65 Million	€-15.19 Million ≈ $-17.76 Million	-0.373x	-256.64%
2014-12-31	€60.90 Million ≈ $71.20 Million	€-6.37 Million ≈ $-7.44 Million	-0.105x	+65.66%
2013-12-31	€29.97 Million ≈ $35.04 Million	€-9.12 Million ≈ $-10.66 Million	-0.304x	+54.29%
2012-12-31	€16.65 Million ≈ $19.47 Million	€-11.09 Million ≈ $-12.96 Million	-0.666x	-366.21%
2011-12-31	€27.90 Million ≈ $32.62 Million	€-3.98 Million ≈ $-4.66 Million	-0.143x	--

About Argen-X

BR:ARGX Belgium Biotechnology

Market Cap

$60.97 Billion

€52.15 Billion EUR

Market Cap Rank

#573 Global

#3 in Belgium

Share Price

€838.60

Change (1 day)

+0.46%

52-Week Range

€583.20 - €912.40

All Time High

€912.40